In a statement, Patrick Vallance, the Chief Scientific Adviser to the British government stated in response to doubts that thave been raised regarding AstraZeneca’s COVID-19 vaccine candidate, the main point about AstraZeneca’s vaccine against COVID-19 was that it worked. “The headline result is the vaccine works and that’s very exciting,” said Vallance during a news…
On Wednesday, in a statement, the University of Cambridge said, it aims to start clinical trials of its COVID-19 candidate in autumn. The development comes in the wake following funding to the tune of 1.9 million pounds from the British government. The approach adopted by the scientists behind the vaccine uses genetic sequences of all…
Going by the results of an early data released by Moderna Inc’s experimental COVID-19 vaccine, which was the first to be tested in the United States, the vaccine produced protective antibodies in a small group of healthy volunteers, said the biotech company. The data comes after a small study on 8 people were done in…
On Tuesday, Australian researchers disclosed, they have mapped the immune responses from one of country’s first coronavirus patients in an important step that closes the gap towards developing a vaccine and treatment for the Wuhan Coronavirus. While the bulk of those infected show only mild symptoms, nearly 20% of the patients are in critical conditions.…
On Wednesday, Sky News reported, a leading British scientist has made a significant breakthrough in the race for a coronavirus vaccine. As a result the normal development time of “two to three years [has been reduced] to just 14 days”, reported Sky news. According to Robin Shattock, head of mucosal infection and immunity at Imperial…
business-gurus.com 